Skip to main content

Books in Pharmaceutical analysis

21-30 of 30 results in All results

Capillary Electrophoresis Methods for Pharmaceutical Analysis

  • 1st Edition
  • Volume 9
  • August 5, 2008
  • Satinder Ahuja + 1 more
  • English
  • eBook
    9 7 8 - 0 - 0 8 - 0 5 5 9 6 1 - 2
Capillary electrophoresis (CE) is a powerful analytical technique that is widely used in research and development and in quality control of pharmaceuticals. Many reports of highly efficient separations and methods have been published over the past 15 years. CE offers several advantages over high-pressure or high-performance liquid chromatography (HPLC). These include simplicity, rapid analysis, automation, ruggedness, different mechanisms for selectivity, and low cost. Moreover, EC requires smaller sample size and yet offers higher efficiency and thus greater resolution power over HPLC. These characteristics are very attractive in research and development, even more so in pharmaceutical quality control (QC) and stability monitoring (SM) studies. This book will provide busy pharmaceutical scientists a complete yet concise reference guide for utilizing the versatility of CE in new drug development and quality control.

Handbook of Pharmaceutical Analysis by HPLC

  • 1st Edition
  • Volume 6
  • February 9, 2005
  • Satinder Ahuja + 1 more
  • English
  • Hardback
    9 7 8 - 0 - 1 2 - 0 8 8 5 4 7 - 3
  • eBook
    9 7 8 - 0 - 0 8 - 0 4 5 5 1 8 - 1
High pressure liquid chromatography–frequently called high performance liquid chromatography (HPLC or, LC) is the premier analytical technique in pharmaceutical analysis and is predominantly used in the pharmaceutical industry. Written by selected experts in their respective fields, the Handbook of Pharmaceutical Analysis by HPLC Volume 6, provides a complete yet concise reference guide for utilizing the versatility of HPLC in drug development and quality control. Highlighting novel approaches in HPLC and the latest developments in hyphenated techniques, the book captures the essence of major pharmaceutical applications (assays, stability testing, impurity testing, dissolution testing, cleaning validation, high-throughput screening).

Profiles of Drug Substances, Excipients and Related Methodology

  • 1st Edition
  • Volume 30
  • December 19, 2003
  • Harry G. Brittain
  • English
  • eBook
    9 7 8 - 0 - 0 8 - 0 5 2 2 6 3 - 0
Whilst following in the footsteps of previous volumes by presenting comprehensive reviews of drug substances and additional materials, this title also heralds a significant expansion of the scope of the series. Traditional contributions will now also be augmented by publication of critical review chapters that summarize information related to the characterization of drug substances and excipients. This change is required to better meet the needs of the pharmaceutical communtiy and to allow the development of a timely vehicle for publishing review materials on this topic.The scope of the Profiles series will encompass review articles and database compilations that fall within one of the following six broad categories: Physical profiles of drug substances and excipients; Analytical profiles of drug substances and excipients; Drug metabolism and pharmacokinetic profiles of drug substances and excipients; Methodologoy related to the characterization of drug substances and excipients; Methods of chemical synthesis; and Reviews of the uses and applications for individual drug substances, classes of drug substances, or excipients.

Handbook of Isolation and Characterization of Impurities in Pharmaceuticals

  • 1st Edition
  • Volume 5
  • June 26, 2003
  • Satinder Ahuja + 1 more
  • English
  • eBook
    9 7 8 - 0 - 0 8 - 0 5 0 7 7 6 - 7
The United States Food and Drug Administration (FDA) and other regulatory bodies around the world require that impurities in drug substance and drug product levels recommended by the International Conference on Harmonisation (ICH) be isolated and characterized. Identifying process-related impurities and degradation products also helps us to understand the production of impurities and assists in defining degradation mechanisms. When this process is performed at an early stage, there is ample time to address various aspects of drug development to prevent or control the production of impurities and degradation products well before the regulatory filing and thus assure production of a high-quality drug product.This book, therefore, has been designed to meet the need for a reference text on the complex process of isolation and characterization of process-related (synthesis and formulation) impurities and degradation products to meet critical requlatory requirements.It's objective is to provide guidance on isolating and characterizing impurities of pharmaceuticals such as drug candidates, drug substances, and drug products. The book outlines impurity identification processes and will be a key resource document for impurity analysis, isolation/synthesis, and characterization.

Analytical Profiles of Drug Substances and Excipients

  • 1st Edition
  • Volume 29
  • November 26, 2002
  • Harry G. Brittain
  • English
  • eBook
    9 7 8 - 0 - 0 8 - 0 8 6 1 2 4 - 1
Although the official compendia define a drug substance as to identity, purity, strength, and quality, they normally do not provide other physical or chemical data, nor do they list methods of synthesis or pathways of physical or biological degradation and metabolism. Such information is scattered throughout the scientific literature and the files of pharmaceutical laboratories. Analytical Profiles of Drug Substances and Excipients brings the latest information together in one source.

Analytical Profiles of Drug Substances and Excipients

  • 1st Edition
  • Volume 28
  • September 19, 2001
  • Harry G. Brittain
  • English
  • eBook
    9 7 8 - 0 - 0 8 - 0 8 6 1 2 3 - 4
Although the official compendia define a drug substance by its identity, purity, strength, and quality, they normally do not provide other physical or chemical data, nor do they list methods of synthesis or pathways of physical or biological degradation and metabolism. Such information is scattered throughout the scientific literature and the files of pharmaceutical laboratories.Edited by the Associate Director of Analytical Research and Development for the American Association of Pharmaceutical Scientists, Analytical Profiles of Drug Substances and Excipients brings this information together in one source. The scope of the series has recently been expanded to include profiles of excipient materials.

Handbook of Modern Pharmaceutical Analysis

  • 1st Edition
  • Volume 3
  • July 26, 2001
  • Satinder Ahuja + 1 more
  • English
  • eBook
    9 7 8 - 0 - 0 8 - 0 4 8 8 9 2 - 9
This book describes the role modern pharmaceutical analysis plays in the development of new drugs. Detailed information is provided as to how the quality of drug products is assured from the point of discovery until the patient uses the drug. Coverage includes state-of-the-art topics such as analytics for combinatorial chemistry and high-throughput screening, formulation development, stability studies, international regulatory aspects and documentation, and future technologies that are likely to impact the field. Emphasis is placed on current, easy-to-follow methods that readers can apply in their laboratories.No book has effectively replaced the very popular text, Pharmaceutical Analysis, that was edited in the 1960s by Tak Higuchi. This book will fill that gap with an up-to-date treatment that is both handy and authoritative.

Analytical Profiles of Drug Substances and Excipients

  • 1st Edition
  • Volume 27
  • March 12, 2001
  • Harry G. Brittain
  • English
  • eBook
    9 7 8 - 0 - 0 8 - 0 8 6 1 2 2 - 7
Although the official compendia define a drug substance as to identity, purity, strength, and quality, they normally do not provide other physical or chemical data, nor do they list methods of synthesis or pathways of physical or biological degradation and metabolism. Such information is scattered throughout the scientific literature and the files of pharmaceutical laboratories.Edited by the Associate Director of Analytical Research and Development for the American Association of Pharmaceutical Scientists, Analytical Profiles of Drug Substances and Excipients brings this information together in one source. The scope of the series has recently been expanded to include profiles of excipient materials.

Analytical Profiles of Drug Substances and Excipients

  • 1st Edition
  • Volume 26
  • October 5, 1999
  • Harry G. Brittain
  • English
  • eBook
    9 7 8 - 0 - 0 8 - 0 8 6 1 2 1 - 0
Although the official compendia define a drug substance as to identity, purity, strength, and quality, they normally do not provide other physical or chemical data, nor do they list methods of synthesis or pathways of physical or biological degradation and metabolism. Such information is scattered throughout the scientific literature and the files of pharmaceutical laboratories. Edited by the Associate Director of Analytical Research and Development for the American Association of Pharmaceutical Scientists, Analytical Profiles of Drug Substances and Excipients brings this information together into one source. The scope of the series has recently been expanded to include profiles of excipient materials.

Analytical Profiles of Drug Substances and Excipients

  • 1st Edition
  • Volume 25
  • March 2, 1998
  • Harry G. Brittain
  • English
  • eBook
    9 7 8 - 0 - 0 8 - 0 8 6 1 2 0 - 3
Although the official compendia define a drug substance as to identity, purity, strength, and quality, they normally do not provide other physical or chemical data, nor do they list methods of synthesis or pathways of physical or biological degradation and metabolism. Such information is scattered throughout the scientific literature and the files of pharmaceutical laboratories. Edited by the Associate Director of Analytical Research and Development for the American Association of Pharmaceutical Scientists, Analytical Profiles of Drug Substances and Excipients brings this information together into one source. The scope of the series has recently been expanded to include profiles of excipient materials.